Filters
FCA and Bank of England discuss data strategy
New compensation order regime applied in UK
Taking security over IP: counting the cost
Intellectual property – commercial drivers
R&I update - January 2020
Clinical Trials – selecting a lawful basis under the GDPR
Mary Rendle considers the challenges of finding the right lawful basis to process personal data for clinical trials.
3 of 6 Insights
GDPR and private sector life sciences
Debbie Heywood takes a high level look at aspects of the GDPR which are particularly relevant to private sector life sciences businesses.
6 of 6 Insights
EU data protection regulators on life sciences and healthcare services
Thanos Rammos looks at the approach of regulators, with a focus on Germany, to the use of personal data in life sciences and healthcare.
5 of 6 Insights
Clinical trials and disaggregation
Jo Joyce discusses finding the balance between better data and best practice for data privacy in clinical trials and medical device testing.
2 of 6 Insights
